Lianne Smith

USPTO Granted Patents = 12 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 70(Granted Patents)

Location History:

Lexington, MA (US) (2015 - 2022)
Cambridge, MA (US) (2018 - 2022)

Company Filing History:

Shire Human Genetic Therapies, Inc.

patents

4. 1 out of 4

Rana Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12453739 - Synergistic enhancement of the delivery of nucleic acids via blended formulations (2025-10-28),

2. 12268754 - Composition and methods for treatment of ornithine transcarbamylase deficiency (2025-04-08),

3. 12201677 - Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency (2025-01-21),

4. 11510937 - CFTR MRNA compositions and related methods and uses (2022-11-29),

5. 11224642 - MRNA therapy for argininosuccinate synthetase deficiency (2022-01-18),

6. 11167043 - Composition and methods for treatment of ornithine transcarbamylase deficiency (2021-11-09),

7. 10835583 - Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency (2020-11-17),

8. 10646504 - Synergistic enhancement of the delivery of nucleic acids via blended formulations (2020-05-12),

9. 10420791 - CFTR MRNA compositions and related methods and uses (2019-09-24),

10. 10130649 - Synergistic enhancement of the delivery of nucleic acids via blended formulations (2018-11-20),

11. 9713626 - CFTR mRNA compositions and related methods and uses (2017-07-25),

12. 9181321 - CFTR mRNA compositions and related methods and uses (2015-11-10),

Title: Lianne Smith: Innovator in Nucleic Acid Delivery

Introduction

Lianne Smith is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the delivery of nucleic acids. With a total of 12 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents is the invention titled "Synergistic enhancement of the delivery of nucleic acids via blended formulations." This patent discloses pharmaceutical compositions that comprise blends of lipid nanoparticles, which are designed to efficiently deliver polynucleotides to target cells, tissues, or organs. The blended compositions enhance the expression of polynucleotides and the production of functional proteins by target cells. Another notable patent is "Composition and methods for treatment of ornithine transcarbamylase deficiency." This invention provides methods for treating this deficiency by administering a composition that includes mRNA encoding an ornithine transcarbamylase protein, aimed at reducing symptoms in affected subjects.

Career Highlights

Lianne has worked with several innovative companies, including Translate Bio, Inc. and Ethris GmbH. Her experience in these organizations has allowed her to develop and refine her groundbreaking inventions in the field of nucleic acid delivery.

Collaborations

Throughout her career, Lianne has collaborated with notable professionals, including Michael W Heartlein and Frank DeRosa. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Lianne Smith is a trailblazer in the field of nucleic acid delivery, with a strong portfolio of patents that showcase her innovative spirit. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.